Showing results (11-20 of 329) with videos related to
Sort By:
Pageof 33
Breast (Edinburgh, Scotland)|October 1, 2013
Mutational analysis of breast cancer: guiding personalized treatmentsMatthew J EllisAdvances in Experimental Medicine and Biology|August 12, 2003
Breast cancer gene expression analysis--the case for dynamic profilingMatthew J EllisClinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 22, 2004
Neoadjuvant endocrine therapy as a drug development strategyMatthew J EllisExpert Opinion on Investigational Drugs|February 7, 2002
FulvestrantKwok Leung Cheung, John F R RobertsonThe Annals of Pharmacotherapy|August 17, 2006
Fulvestrant: pharmacologic profile versus existing endocrine agents for the treatment of breast cancerAman U Buzdar, John F R RobertsonCancer Chemotherapy and Pharmacology|July 25, 2003
Equivalent single-dose pharmacokinetics of two different dosing methods of prolonged-release fulvestrant ('Faslodex') in postmenopausal women with advanced breast cancerJohn F R Robertson, M P HarrisonBreast Cancer Research : BCR|September 1, 2010
Microarray data analysis in neoadjuvant biomarker studies in estrogen receptor-positive breast cancerJingqin Luo, Matthew J EllisBreast Cancer Research and Treatment|November 21, 2007
Letrozole in the neoadjuvant setting: the P024 trialMatthew J Ellis, Cynthia MaAmerican Journal of Clinical Oncology|August 7, 2003
Role of biologic markers in patient selection and application to disease preventionMitch Dowsett, Matthew J EllisWorld Journal of Surgical Oncology|September 13, 2011
Clinical relevance of "withdrawal therapy" as a form of hormonal manipulation for breast cancerAmit Agrawal, John F R Robertson, K L CheungPageof 33